Lincoln Pharmaceuticals sets up an Ultramodern State of Art unit for Injectable manufacturing

13 Jan 2014 Evaluate

Lincoln Pharmaceuticals has setup an Ultramodern State of Art unit for manufacturing Injectables. The Unit is manufacturing Liquid Injectables like Ampoules, Vials, Dry Powder Injectable and Liquid Syrup in this new facility. With an investment of nearly Rs 27 crore, the Company has set up an ultramodern state of art unit and aiming to get USFDA and MHRA certification.

With this new facility, the company is achieving Rs 50 crore additional turnovers during this financial year and bottom line will also improve accordingly. With this new facility, the company can produce all therapeutic medicines. Therefore, there is lot of opportunity to introduce the new product line and enter into new segment.Manufacturing facilities at Lincoln Pharmaceuticals are in accordance with WHO-GMP standards and ISO 9001 certification. 

Lincoln Pharmaceutical is a Public Company with a large shareholder base. It has its own manufacturing facilities, covering all the major dosage forms like Tablets, Capsules, Injectables, Syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad.

Lincoln Pharma Share Price

617.50 -0.15 (-0.02%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.